期刊文献+

血小板活化因子与新生儿疾病 被引量:5

Platelet-Activating Factors and Neonatal Diseases
原文传递
导出
摘要 血小板活化因子(PAF)是一种磷脂信号分子,主要通过细胞膜表面的PAF受体(PAF-R)———G蛋白耦联受体,将细胞内信号传导至多种类型的细胞效应器。PAF在多种有害刺激下与PAF-R结合并发生磷酸化,激活信号传导通路及细胞内第二信使,如环磷酸鸟苷、磷脂酰肌醇、磷脂酶C、磷酸肌酸激酶及钙离子等生物效应,并可介导转录因子如核因子(NF)-κB的活化,激发并扩大急性炎症和凝血反应等,从而介导参与多种疾病的病理过程。在脓毒症、休克、创伤中,PAF信号系统失调,中断效应器反应会引起好的结果。随着研究深入,发现PAF与新生儿疾病的发生、发展有密切关系。现就PAF的结构、代谢、功能及其与新生儿疾病的相关性进行综述。 Platelet -activating factor(PAF) is a phospholipid signaling molecule. It evokes its effects by binding to its G protein - coupled receptor, and transmits outside -in signals to intracellular transduction effectors in a variety of cell types. Injurious stimuli ceiaget PAF - R phosphorylation, activate signal transduction pathways and intracellular second messengers such as cyclic guanosine monophosphate,phosphatidylinositol, phospholipase C, creatine phosphate kinases and calcium and other biological effects, and mediate transcription facters such as nuclear factor(NF) - KB activation, trigger and amplify both acute inflammatory and thrombotic cascades. PAF mediates in the pachogenesis of many diseases. The PAF signaling system could not play its role in sepsis, shock, and traumatic injury and that interruptmn or termination of its effector responses leads to beneficial outcomes. With further research, it was found that PAF and neonatal diseases have a close relationship. In this paper, the structure of PAF, metabolism, function, and its correlation with neonatal disease were reviewed, which przvide a new direction on the pathogenesis of the disease, and provide a new method for diagnosis and treatment.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2011年第24期1893-1895,共3页 Journal of Applied Clinical Pediatrics
基金 河南省科技攻关项目(083SGYS33263-5)
关键词 血小板活化因子 血小板活化因子受体 G蛋白耦联受体 新生儿疾病 platelet -activating factor platelet- activating factor receptor G protein -coupled receptor neonatal diseasea
  • 相关文献

参考文献27

  • 1Edwards LJ, Constantinescu CS. Platelet activating factor/platelet activating factor receptor pathway as a potential therapeutic target in autoimmune diseases [ J ]. lnflamm Allergy Drug Targets, 2009,8 ( 3 ) : 182 - 190.
  • 2Jeong YI, Jung ID, Lee CM, et al. The novel role of platelet activating factor in protecting mice against lipopolysaccharide - induced endotoxic shock [ J ]. PLoS One,2009, 4 ( 8 ) : e6503.
  • 3陈学林.运用萎凋工艺改进银杏叶茶品质的研究[J].林业科技开发,2004,18(1):30-31. 被引量:8
  • 4陈学林.银杏芽茶杀青工艺的探讨[J].中国林副特产,2002(4):33-34. 被引量:4
  • 5Diana M. Stafforini, Biology of platelet - activating factor acetylhydrolase ( PAF - AH), lipoprotein associated phospholipase A2[J]. Cardiovasc Drugs Ther ,2009 ,23 ( 1 ) :73 - 83.
  • 6Detopoulou P, Nomikos T, Fragopoulou E, et al. Platelet activating factor (PAF) and activity of its biosynthetic and catabolic enzymes in blood and leukocytes of male patients with newly diagnosed heart failure[J]. Clin Biochem, 2009,42 ( 1 - 2 ) :44 - 49.
  • 7Stafforini DM, Satoh K, Atkinson DL, et al. Platelet activating factor acetylhydrolase deficieney. A missense mutati on near the activesite of anti - inflammatory phospholipase [ J ]. J Clin Invest, 1996, 9 ( 7 ) :2784 -2791.
  • 8Liu J, Chen R, Marathe GK,et al. Circulating platelet - activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein- associated phospholipase A2/PAF acetylhydrolase [ J ]. Circ Res,2011,108(4) :469 -477.
  • 9Renteria LS, Raj JU, Ibe BO. Prolonged hypoxia modulates platelet activating factor receptor - mediated responses by fetal ovine pulmonary vaseular smooth muscle cells [ J ]. Mol Genet Metab, 2010 , 101 (4) :400 - 408.
  • 10Bixby CE, Ibe BO, Abdallah MF, et al. Role of platelet - activating factor in pulmonary vascular remodeling associated with chronic high altitude hypoxia in ovine fetal lambs [ J ]. Am J Physiol Lung Cell Mol Physiol,2007,293 (6) : L1475 - 1482.

二级参考文献72

共引文献95

同被引文献33

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部